Java turned 30 in 2025. That's a good time to look back, but also forward.

Enliven Therapeutics Inc. (Nasdaq: ELVN) reported this week that as of the end of 2025, the clinical-stage precision oncology company has $462.6 million in cash and equivalents, enough runway to fund ...

Iran's supreme leader is dead, but the regime remains intact. A new leader is expected to be picked in days, and the choice could dictate the course of the conflict.

Wounded, ill, and injured active-duty soldiers and veterans from across the country have been competing at Fort Bliss since last month for a chance to represent ...

In Part 4, Carolyn Krause learns more about the processes behind BWXT and LIS Technologies, which will be part of the nuclear ...